Medical Marijuana: Risks and Benefits Malcolm P. Rogers, M.D. Portland VA Clinic malcolm....
-
Upload
duane-stokes -
Category
Documents
-
view
216 -
download
4
Transcript of Medical Marijuana: Risks and Benefits Malcolm P. Rogers, M.D. Portland VA Clinic malcolm....
Medical Marijuana: Risks and Benefits
Malcolm P. Rogers, M.D.Portland VA Clinic
malcolm. [email protected]
Brief History
• Long History of Use as Herbal Medicine• 1937: Severely Restricted – Medical Marijuana
Tax Act• 1970 : Controlled Substances Act – Places
marijuana into Schedule 1• 1996: California law sanctions medical use of
marijuana and protects patients and providers from prosecution
History (continued)
• 2005 US Supreme Court (Gonzales v Raich) overturns California’s law by 6-3 vote
• About a dozen other states allow medical marijuana
• October 2009: Obama Administration discourages US Attorneys from taking enforcement actions in medical marijuana states
• November 2009: Maine votes yes on medical marijuana dispensaries
Medical Community Response
• February 2009: American College of Physicians calls for “evidence-based review of marijuana’s status as Schedule 1 controlled substance to determine whether” to reclassify
• November 2009: AMA voted to change classification, affirming therapeutic benefits for neuropathic pain, improving appetite and relieving spasticity and pain in MS patients
Biology of Cannabis• Cannabis is complex: plant contains over 60
cannabinoid molecules and 500 total compounds• 1964: Active substance in herbal marijuana found
to be delta-9-tetrohydrocannabinol (THC)• 1990: CB1 & CB2 receptors binding THC &
endocannabinoids soon discovered• Receptors primarily in frontal regions of cortex
but also in basal ganglia, cerebellum, hypothalamus , pituitary, anterior cingulate gyrus, spinal cord and peripheral nervous system
Biology of Cannabis
• CB1 receptors also found in fat and muscle cells
• CB1 most abundant G protein-coupled receptor in brain
• THC acts by inhibiting the release of neurotransmitters: L-glutamate, GABA, noradrenaline, dopamine, serotonin and acetylcholine
Potential Therapeutic Role
• Regulation of hunger and weight• Regulates fat cells, lipids and glucose• Preventing action of CB1 receptor reduces
nicotine dependence• Rimonabant trials were not successful and drug
withdrawn from European market• HPA axis:– potential effect on stress response, fertility and
sexual response
Benefits - Cancer Chemotherapy
• Tramer et al: BMJ 323: 16, 2001– 30 randomized comparisons with other antiemetics,
1336 patients: reduced nausea and vomiting more than other agents• Good side effects: high, euphoria, sedation• Bad side effects: dizziness, dysphoria, paranoia
• Machado-Rocha FC, et. Al: Eur. J. Cancer Care 17:431, 2008– Systematic review and meta-analyses showed superiority
of cannabis over placebo and conventional drugs - but more adverse effects
Stimulates Appetite
• Anorexia in chemotherapy treated cancer patients
• Wasting in HIV/AIDS – One of the oral preparations dronabinol (Marinol)
is approved for anorexia associated with AIDS
MS and Neuropathic Pain
• MS Spasticity – relieves muscle spasticity and related pain
• Ghaffar et al. Neurology 71:164, 2008.
• Neuropathic Pain – both central and peripheral
• Abrams D et al. Neurology 68:515, 2007.
Possible Benefits
• Reduction of anxiety and anger in occasional, non-medical users – anecdotal evidence for as well as against in terms
of panic attacks and paranoia
• Arthritis, asthma, migraine, motor tics, ALS, cerebral palsy, gastrointestinal (Crohn’s), glaucoma, hepatitis C, neuroprotection and chronic pain
Adverse Effects – Psychosis Risk• Systematic review of longitudinal and population based studies• 7 studies • Risk of developing psychosis– 2.58 times more likely if ever used– Confounding factors :
• Reverse causation, intoxication• Suggestion that risk higher if use occurs before age 16
– Moore et al, Lancet 370: 319,2007
– Moore et al. Lancet 370: 319, 2007
Adverse Effects – Psychosis Risk
• Only small percentage of people using marijuana develop psychosis
• In existing psychosis, marijuana use can exacerbate symptoms, worsen course, trigger relapse
• Insufficient alone to cause psychosis but interacts with other risk factors– Family hx, neurobehavioral deficits, social withdrawal
– Moore et al. Lancet 370: 319, 2007
Adverse Effects – Mood & Affect
• Affective dysregulation in adolescents • Amotivational Syndrome• Limited support from systematic meta-
analyses for increased depression risk• Anxiety – case reports of panic disorder but
overall data unclear.
Adverse Effects – Cognition and Memory
• Acute effects on visuo-spatial working memory• Impairs executive function in short term
abstinent cannabis users• Memory problems can persist for one month
after last use but long term effects unclear• fMRI suggests that neurodevelopment might be
altered in adolescents with persistent neurocognitive deficits
Other Adverse Effects
• Addictive Potential• Association with relapse in other substance
abuse, for example, opioid abuse in suboxone patients
• Risks associated with legal prohibition• Marijuana smoke and medical risk
Adverse Effects - Medical
• Potential increased risk of cancer and cardiovascular disease– Cannabis smoke delivers 50-70% more
carcinogenic hydrocarbons than tobacco smoke– Higher risk of cardiac arrhythmias
• Oral (Marinol) or sublingual preparations (Sativa) alternatives but might not be as effective
Summary• Benefits: – nausea and appetite in cancer– spasticity in MS– neuropathic pain
• Risks: (mostly in high frequency recreational users):– psychosis– cognitive impairment– mood and motivation– medical